425 related articles for article (PubMed ID: 32973527)
21. Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells.
Ma M; Badeti S; Geng K; Liu D
bioRxiv; 2020 Aug; ():. PubMed ID: 32817942
[TBL] [Abstract][Full Text] [Related]
22. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A; Vilches C; Angulo A; López-Botet M
Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
[TBL] [Abstract][Full Text] [Related]
23. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
[TBL] [Abstract][Full Text] [Related]
24. [Lectin populations of NK cells against tumors coupled to viral infections (review of literature).].
Lakhtin VM; Lakhtin MV; Mironov AY; Aleshkin VA; Аfanasiev SS
Klin Lab Diagn; 2019; 64(5):314-320. PubMed ID: 31185156
[TBL] [Abstract][Full Text] [Related]
25. Natural Killer Cells in Human Immunodeficiency Virus-1 Infection: Spotlight on the Impact of Human Cytomegalovirus.
Peppa D
Front Immunol; 2017; 8():1322. PubMed ID: 29089947
[TBL] [Abstract][Full Text] [Related]
26. The role of NK cells in fighting the virus infection and sepsis.
Ma L; Li Q; Cai S; Peng H; Huyan T; Yang H
Int J Med Sci; 2021; 18(14):3236-3248. PubMed ID: 34400893
[TBL] [Abstract][Full Text] [Related]
27. KIR Polymorphism Modulates the Size of the Adaptive NK Cell Pool in Human Cytomegalovirus-Infected Individuals.
Manser AR; Scherenschlich N; Thöns C; Hengel H; Timm J; Uhrberg M
J Immunol; 2019 Oct; 203(8):2301-2309. PubMed ID: 31519864
[TBL] [Abstract][Full Text] [Related]
28. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.
Hammer Q; Rückert T; Borst EM; Dunst J; Haubner A; Durek P; Heinrich F; Gasparoni G; Babic M; Tomic A; Pietra G; Nienen M; Blau IW; Hofmann J; Na IK; Prinz I; Koenecke C; Hemmati P; Babel N; Arnold R; Walter J; Thurley K; Mashreghi MF; Messerle M; Romagnani C
Nat Immunol; 2018 May; 19(5):453-463. PubMed ID: 29632329
[TBL] [Abstract][Full Text] [Related]
29. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.
Rölle A; Halenius A; Ewen EM; Cerwenka A; Hengel H; Momburg F
Eur J Immunol; 2016 Oct; 46(10):2420-2425. PubMed ID: 27469079
[TBL] [Abstract][Full Text] [Related]
30. Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients.
Béziat V; Sleiman M; Goodridge JP; Kaarbø M; Liu LL; Rollag H; Ljunggren HG; Zimmer J; Malmberg KJ
Front Immunol; 2015; 6():507. PubMed ID: 26500647
[TBL] [Abstract][Full Text] [Related]
31. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
32.
Liu LL; Béziat V; Oei VYS; Pfefferle A; Schaffer M; Lehmann S; Hellström-Lindberg E; Söderhäll S; Heyman M; Grandér D; Malmberg KJ
Cancer Immunol Res; 2017 Aug; 5(8):654-665. PubMed ID: 28637877
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
35. Exploring the Utility of NK Cells in COVID-19.
Deng X; Terunuma H; Nieda M
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625739
[TBL] [Abstract][Full Text] [Related]
36. Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
Al-Ani M; Elemam NM; Hundt JE; Maghazachi AA
Infect Drug Resist; 2020; 13():3243-3254. PubMed ID: 33061471
[TBL] [Abstract][Full Text] [Related]
37. CAR-NK Cells Effectively Target the D614 and G614 SARS-CoV-2-infected Cells.
Ma M; Badeti S; Chen CH; Pinter A; Jiang Q; Shi L; Zhou R; Xu H; Li Q; Gause W; Liu D
bioRxiv; 2021 Jan; ():. PubMed ID: 33469580
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.
Wu Z; Frascaroli G; Bayer C; Schmal T; Mertens T
J Virol; 2015 Jun; 89(12):6435-41. PubMed ID: 25855747
[TBL] [Abstract][Full Text] [Related]
39. Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells.
Riese P; Trittel S; Pathirana RD; Klawonn F; Cox RJ; Guzmán CA
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32517137
[TBL] [Abstract][Full Text] [Related]
40. CMV induces rapid NK cell maturation in HSCT recipients.
Della Chiesa M; Muccio L; Moretta A
Immunol Lett; 2013; 155(1-2):11-3. PubMed ID: 24076315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
